Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
ESSA Pharma to Participate in Multiple Upcoming Investor Conferences
-
Spero Therapeutics (SPRO) Announces Proposed 8M Share Common Offering
-
Spero Therapeutics Announces Proposed Public Offering
-
Spero Therapeutics Announces Proposed Public Offering
-
HighCape Capital Acquisition Corp. Announces Closing of $115 Million Initial Public Offering
-
Xencor to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
-
Pipeline Therapeutics to Present at Two Upcoming Investor Conferences
-
Makor Group Hires New Vice President For Middle East Operations, Daniel Nevo
-
TG Therapeutics to Present at Upcoming Investor Conferences
-
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
-
Veru to Participate and Present at Four Upcoming Healthcare Investor Conferences
-
VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitzgerald and H.C. Wainwright Investment Conferences in September
-
Rigel to Present at Two Upcoming Investor Conferences
-
Haymaker, ARKO Holdings Ltd. and GPM Investments, LLC Announce Business Combination
-
Haymaker, ARKO Holdings Ltd. and GPM Investments, LLC Announce Business Combination
-
Cohen & Company and INSU Acquisition Corp. II Announce Completion of INSU Acquisition Corp. II $230,000,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option
-
Cohen & Company and INSU Acquisition Corp. II Announce Completion of INSU Acquisition Corp. II $230,000,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option
-
Cantor Fitzgerald Starts Entasis Therapeutics (ETTX) at Overweight
-
HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences
-
PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
-
PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
-
Rockwell Medical, Inc. to Present at Upcoming September Investor Conferences
-
Ardelyx to Participate in Three Upcoming Investor Conferences in September
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Rockwell Medical, Inc. to Present at Upcoming September Investor Conferences
-
I-Mab Announces Upcoming Participation at September Conferences
-
Strongbridge Biopharma plc Provides Corporate Update
-
Frequency Therapeutics to Present at Upcoming Investor Conferences and Medical Meetings
-
Arrowhead Pharmaceuticals to Participate in Upcoming September 2020 Conferences
-
Provention Bio to Present at Upcoming Virtual Investor Conferences
-
Axovant Announces First Parkinson's Disease Gene Therapy R&D Day and Participation in Upcoming September Conferences"
-
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in September
-
Evelo Biosciences to Participate in Upcoming Investor Conferences in September
-
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
-
Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September
-
Aravive to Participate in Upcoming Virtual Investor Conferences in September
-
Codexis to Present at Two Virtual Investment Conferences in September
-
Evelo Biosciences to Participate in Upcoming Investor Conferences in September
-
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
-
Anavex Life Sciences to Present at Upcoming Global Healthcare Conferences
-
Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September
-
E.Merge Technology Acquisition Corp. Announces Closing of Underwriters’ Option to Purchase Additional Units in Connection with its Initial Public Offering
-
E.Merge Technology Acquisition Corp. Announces Closing of Underwriters’ Option to Purchase Additional Units in Connection with its Initial Public Offering
-
Aridis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Sabina Gold and Silver Corp. (SBB:CN) (SGSVF) PT Raised to Cdn$3.40 at Cantor Fitzgerald, Earlier
-
Surgalign Holdings, Inc. to Present at the Cantor Virtual Global Healthcare Conference
-
Surgalign Holdings, Inc. to Present at the Cantor Virtual Global Healthcare Conference
-
Fate Therapeutics Announces September Investor Events
-
Pliant Therapeutics To Participate In Upcoming Virtual Investor Conferences

